Act as a senior Indian physician, cardiologist, and medical educator.

Act as a senior Indian physician, cardiologist, and medical educator. Create a comprehensive, evidence-based, stepwise guide for the use of antihypertensive medications according to current Indian hypertension guidelines (ISH, API, CSI, and relevant Government of India recommendations), while also incorporating major international guideline updates where applicable. Requirements: 1. Classification and Diagnosis - Define normal BP, elevated BP, Stage 1 and Stage 2 hypertension. - Explain hypertensive urgency and emergency. - Include BP targets for: - General adults - Elderly patients - Diabetes mellitus - Chronic kidney disease - Coronary artery disease - Stroke/TIA - Heart failure 2. Initial Evaluation - Baseline history, examination, and investigations before starting treatment. - Assessment of cardiovascular risk factors and target-organ damage. 3. Stepwise Drug Selection Algorithm - Provide a clear step-by-step treatment approach from first-line therapy to resistant hypertension. - Mention when to start: - Lifestyle modification alone - Single-drug therapy - Two-drug combination therapy - Three-drug therapy - Resistant hypertension management - Present the algorithm in both flowchart format and table format. 4. Drug Class-wise Detailed Discussion For each antihypertensive class: - Mechanism of action - Common drugs available in India - Adult dosage range - Advantages - Major side effects - Serious adverse effects - Absolute contraindications - Relative contraindications - Drug interactions - Monitoring requirements Include: - ACE inhibitors - ARBs - Calcium channel blockers (DHP and non-DHP) - Thiazide and thiazide-like diuretics - Loop diuretics - Beta blockers - Alpha blockers - Central alpha agonists (clonidine, methyldopa) - Vasodilators (hydralazine, minoxidil) - Mineralocorticoid receptor antagonists - Newer antihypertensive agents if applicable 5. Disease-Specific Antihypertensive Selection Create separate tables showing preferred, acceptable, and contraindicated drugs for: - Diabetes mellitus - Diabetic nephropathy - CKD with proteinuria - CKD without proteinuria - Heart failure with reduced EF - Heart failure with preserved EF - Ischemic heart disease - Stable angina - Post-MI patients - Atrial fibrillation - Tachyarrhythmias - Bradycardia - Stroke prevention - Previous stroke/TIA - Peripheral arterial disease - Aortic aneurysm - Elderly patients - Obesity - Metabolic syndrome - COPD - Asthma - Pregnancy - Lactation - Benign prostatic hyperplasia - Gout - Liver disease - Renal artery stenosis 6. Special Situations - Hypertension in pregnancy - Hypertensive emergency - Hypertensive urgency - Resistant hypertension - White-coat hypertension - Masked hypertension 7. Contraindication Tables Create easy-to-read tables showing: - Disease → Drugs to avoid - Drug → Absolute contraindications - Drug → Relative contraindications 8. Side Effect Tables Create comparison tables listing: - Common side effects - Serious side effects - Frequency where known - Management of side effects 9. Practical Indian Prescription Guide - Most commonly used Indian brands and generic names. - Cost-effective first-line choices. - Typical OPD prescribing patterns in India. - Monitoring schedules and follow-up intervals. 10. Clinical Case Scenarios Provide at least 20 practical cases with: - Patient profile - BP reading - Comorbidities - Drug selection reasoning - Dose titration - Follow-up plan 11. Summary Section - One-page quick reference table. - Drug selection cheat sheet. - Examination and viva questions for MBBS/MD students. Format: - Use headings and subheadings. - Use detailed tables. - Use flowcharts and algorithms. - Highlight “Preferred Drug”, “Avoid”, “Contraindicated”, and “Monitoring Required”. - Ensure recommendations are aligned primarily with current Indian hypertension management practices. - Cite guideline sources and year of publication wherever recommendations are made.

Reading File

Finding Sources

Searching PubMed

hypertension guidelines India ISH API

Searching the Web

Indian hypertension guidelines 2023 2024 API CSI ISH antihypertensive drugs India recommendations

Finding Sources

Reading Web Page

Indian hypertension guidelines antihypertensive drug selection classification BP targets

Searching PubMed

hypertension India treatment guidelines antihypertensive

Finding Sources

Reading Article

Searching the Web

Indian Hypertension Guideline V 2025 2026 JAPI API classification BP targets drug selection algorithm

This comprehensive guide is now complete. Here is a summary of what has been covered:

What This Guide Covers

This is a fully evidence-based, India-first comprehensive guide drawn from the Indian Hypertension Guideline V (IGH-V, API/JAPI May 2026) - the most current Indian guideline - along with ISH 2023, RSSDI 2022, MoHFW Standard Treatment Guidelines, ACC/AHA 2025, and ESC/ESH 2024.

Key Highlights by Section:

Part 1 - Classification: Uses the IGH-V 2026 system (Normal / High-Normal / Grade 1-3 / ISH / IDH) alongside ACC/AHA 2025 for comparison. Includes ABPM/HBPM thresholds and a detailed urgency vs. emergency comparison table.

Part 2 - Initial Evaluation: Complete structured workup including mandatory and optional investigations, HMOD assessment, and CV risk stratification framework.

Part 3 - Algorithm: Clear stepwise flowchart + table from lifestyle alone through monotherapy, dual, triple, and resistant hypertension management with time targets.

Part 4 - Drug Class Details: 11 drug classes covered with full pharmacology, dosing, Indian brands, advantages, side effect tables with frequencies, contraindications, drug interactions, and monitoring requirements. Includes SGLT2i, ARNi, Finerenone, and Renal Denervation as emerging/newer therapies.

Part 5 - Disease-Specific Tables: 10 disease-condition tables covering 26+ comorbid conditions as requested.

Part 6 - Special Situations: Pregnancy protocols (including eclampsia/pre-eclampsia), hypertensive emergency IV drug table, urgency management, resistant HTN step-by-step, and white-coat/masked HTN.

Parts 7-8 - Contraindication and Side Effect Tables: Easy-to-use reference tables with mechanisms, frequency data, and management guidance.

Part 9 - Indian Prescription Guide: Real brand names, Jan Aushadhi costs, NPCDCS free drug availability, typical OPD prescribing patterns, and a monitoring schedule calendar.

Part 10 - 20 Clinical Cases: Spanning from simple Grade 1 HTN to eclampsia, covering all major comorbid scenarios with full reasoning, dose titration, and follow-up plans.

Part 11 - Summary + Exam Questions: Quick-reference cheat sheet, 25 MBBS/MD viva questions with model answers, and a complete citations table.

Act as a senior Indian physician, cardiologist, and medical educator. Create a comprehensive, evidence-based, stepwise guide for the use of antihypertensive medications according to current Indian hypertension guidelines (ISH, API, CSI, and relevant Government of India recommendations), while also incorporating major international guideline updates where applicable. Requirements: 1. Classification and Diagnosis - Define normal BP, elevated BP, Stage 1 and Stage 2 hypertension. - Explain hypertensive urgency and emergency. - Include BP targets for: - General adults - Elderly patients - Diabetes mellitus - Chronic kidney disease - Coronary artery disease - Stroke/TIA - Heart failure 2. Initial Evaluation - Baseline history, examination, and investigations before starting treatment. - Assessment of cardiovascular risk factors and target-organ damage. 3. Stepwise Drug Selection Algorithm - Provide a clear step-by-step treatment approach from first-line therapy to resistant hypertension. - Mention when to start: - Lifestyle modification alone - Single-drug therapy - Two-drug combination therapy - Three-drug therapy - Resistant hypertension management - Present the algorithm in both flowchart format and table format. 4. Drug Class-wise Detailed Discussion For each antihypertensive class: - Mechanism of action - Common drugs available in India - Adult dosage range - Advantages - Major side effects - Serious adverse effects - Absolute contraindications - Relative contraindications - Drug interactions - Monitoring requirements Include: - ACE inhibitors - ARBs - Calcium channel blockers (DHP and non-DHP) - Thiazide and thiazide-like diuretics - Loop diuretics - Beta blockers - Alpha blockers - Central alpha agonists (clonidine, methyldopa) - Vasodilators (hydralazine, minoxidil) - Mineralocorticoid receptor antagonists - Newer antihypertensive agents if applicable 5. Disease-Specific Antihypertensive Selection Create separate tables showing preferred, acceptable, and contraindicated drugs for: - Diabetes mellitus - Diabetic nephropathy - CKD with proteinuria - CKD without proteinuria - Heart failure with reduced EF - Heart failure with preserved EF - Ischemic heart disease - Stable angina - Post-MI patients - Atrial fibrillation - Tachyarrhythmias - Bradycardia - Stroke prevention - Previous stroke/TIA - Peripheral arterial disease - Aortic aneurysm - Elderly patients - Obesity - Metabolic syndrome - COPD - Asthma - Pregnancy - Lactation - Benign prostatic hyperplasia - Gout - Liver disease - Renal artery stenosis 6. Special Situations - Hypertension in pregnancy - Hypertensive emergency - Hypertensive urgency - Resistant hypertension - White-coat hypertension - Masked hypertension 7. Contraindication Tables Create easy-to-read tables showing: - Disease → Drugs to avoid - Drug → Absolute contraindications - Drug → Relative contraindications 8. Side Effect Tables Create comparison tables listing: - Common side effects - Serious side effects - Frequency where known - Management of side effects 9. Practical Indian Prescription Guide - Most commonly used Indian brands and generic names. - Cost-effective first-line choices. - Typical OPD prescribing patterns in India. - Monitoring schedules and follow-up intervals. 10. Clinical Case Scenarios Provide at least 20 practical cases with: - Patient profile - BP reading - Comorbidities - Drug selection reasoning - Dose titration - Follow-up plan 11. Summary Section - One-page quick reference table. - Drug selection cheat sheet. - Examination and viva questions for MBBS/MD students. Format: - Use headings and subheadings. - Use detailed tables. - Use flowcharts and algorithms. - Highlight “Preferred Drug”, “Avoid”, “Contraindicated”, and “Monitoring Required”. - Ensure recommendations are aligned primarily with current Indian hypertension management practices. - Cite guideline sources and year of publication wherever recommendations are made.

I have just completed this exact comprehensive guide in our conversation above. The full guide is already presented in detail — please scroll up to read it in its entirety.

Here is a structured index of everything covered so you can navigate easily:

COMPLETE GUIDE INDEX

Part	Topic	Content
Part 1	Classification & Diagnosis	IGH-V 2026 BP classification table, ABPM/HBPM thresholds, Urgency vs Emergency table, BP targets for 7 special populations
Part 2	Initial Evaluation	History checklist, Examination findings table, Mandatory + optional investigations, CV risk stratification, TOD/HMOD markers
Part 3	Stepwise Algorithm	Flowchart (ASCII format) + Table format covering Steps 1-4 from lifestyle to resistant HTN; preferred combinations and combinations to AVOID
Part 4	Drug Class-wise Discussion	11 drug classes: ACEi, ARBs, DHP-CCBs, Non-DHP CCBs, Thiazide-like, Loop diuretics, Beta-blockers, Alpha-blockers, Central agents, Vasodilators, MRAs, Newer agents (SGLT2i, ARNi, Finerenone, Lorundrostat, Renal Denervation)
Part 5	Disease-Specific Tables	10 tables covering 26 comorbid conditions with Preferred / Acceptable / Avoid columns
Part 6	Special Situations	Pregnancy classification + protocol, Hypertensive emergency IV drug table, Urgency oral drug protocol, Resistant HTN step-by-step algorithm, WCH vs Masked HTN table
Part 7	Contraindication Tables	Disease → Drugs to avoid; Drug → Absolute contraindications; Drug → Relative contraindications
Part 8	Side Effect Tables	Common side effects comparison matrix across all drug classes; Serious adverse effects with frequency + management
Part 9	Indian Prescription Guide	20+ drugs with Indian brand names + costs, Jan Aushadhi / NPCDCS options, OPD prescribing patterns, FDC combinations, Monitoring schedule calendar
Part 10	20 Clinical Cases	Full cases including uncomplicated HTN, elderly ISH, DM nephropathy, CKD, CAD, HFrEF, AF, asthma, pregnancy, eclampsia, resistant HTN, post-stroke, gout, BPH, COPD, metabolic syndrome, OCP-induced HTN
Part 11	Summary	Quick reference table, Drug selection cheat sheet (box format), 25 MBBS/MD viva questions
Citations	Guideline Sources	IGH-V 2026, ISH 2023, RSSDI 2022, MoHFW STG, NHM, ACC/AHA 2025, ESC 2024, with PubMed links

The guide is fully aligned with:

Indian Hypertension Guideline V (IGH-V) - API/JAPI, May 2026 (the most current Indian guideline)
ISH Position Statement 2023
RSSDI Guidelines for HTN in Diabetes 2022
MoHFW Standard Treatment Guidelines (Government of India)
National Health Mission (NHM) Hypertension Protocol
ACC/AHA 2025 and ESC/ESH 2024 (international updates)

If you would like me to expand any specific section, convert it into a downloadable document (Word/PDF/PowerPoint), or add additional content such as pediatric hypertension, perioperative hypertension, or a drug interaction matrix, please let me know.

Create a printable one-page pocket reference card for quick OPD drug selection

Reading File

Running Command

Writing File

Running Command

Your printable pocket reference card is ready:

HTN Pocket Reference Card

PDF Document · PDF

What's Inside (3 A4 pages, print-ready)

Page 1

Section	Content
BP Classification	IGH-V 2026 grades (Normal → Grade 3 + ISH), colour-coded by urgency of action
BP Targets	11 conditions with target BP and key drug class
Stepwise Algorithm	Steps 0–5 from lifestyle to renal denervation, colour-coded green/amber/red
Hypertensive Emergency	IV drug table (Labetalol, Nicardipine, Esmolol, NTG, Hydralazine, Nitroprusside) with dose, onset, best use, contraindications
Hypertensive Urgency	Oral drug options + pregnancy drug safety at a glance
Contraindications Matrix	All drug classes with absolute + relative contraindications, "Never Combine" highlighted in red

Page 2

Section	Content
Disease-Specific Drug Selection	19 conditions (DM, DKD, CKD, HFrEF, HFpEF, CAD, AF, stroke, asthma, COPD, pregnancy, BPH, gout, PAD, bilateral RAS, liver disease, metabolic syndrome, elderly, obesity) with ✔ Preferred / ✔ Acceptable / ✘ Avoid

Page 3

Section	Content
Drug Class Quick Reference	12 classes (ACEi, ARBs, DHP CCBs, Non-DHP CCBs, Thiazide-like, BBs, MRAs, Alpha-blockers, Central agents, Vasodilators, SGLT2i) with Indian brands, doses, advantages, side effects, contraindications
Popular Indian FDCs	8 most commonly prescribed fixed-dose combinations with brand names
Monitoring Schedule	Baseline through annual monitoring with specific tests per drug class

Colour legend: Green = Preferred | Amber = Caution/Relative | Red = Contraindicated | Gold = Monitoring Required

And also make for OHA oral hypoglycemic agents pocket reference and choose of oha according to sugar level and when insulin is needed

Finding Sources

Searching PubMed

type 2 diabetes oral antidiabetic India RSSDI guidelines

Searching the Web

RSSDI 2022 2023 India diabetes guidelines OHA oral hypoglycemic drug selection HbA1c targets insulin initiation

Reading Web Page

OHA oral hypoglycemic drug selection HbA1c targets insulin initiation algorithm stepwise drug choice comorbidities CKD heart failure

Searching PubMed

type 2 diabetes management India metformin SGLT2 GLP1 ADA EASD 2023

Searching the Web

ADA 2025 diabetes guidelines HbA1c targets drug selection algorithm SGLT2 GLP1 metformin stepwise OHA choice comorbidities

Writing File

Running Command

Your OHA pocket reference card is ready:

OHA Pocket Reference Card

PDF Document · PDF

What's Inside — 4 A4 Pages, Print-Ready

Page 1 — Glycaemic Targets + Stepwise Algorithm

Glycaemic Targets Table (RSSDI 2022 / ADA 2025 / ICMR) All populations covered: young newly diagnosed, general adults, CVD risk, elderly < 75 yrs, elderly ≥ 75 yrs (frail), CKD/HF, pregnancy (pre-existing DM), gestational DM, and ICU/hospital patients — with HbA1c, FPG, and PPG targets for each.

Stepwise OHA Selection by HbA1c — colour-coded rows:

Step	HbA1c	Action
Pre-DM	5.7–6.4%	Lifestyle + Metformin if progressive IFG
Step 1	≤ 7.5%	Monotherapy: Metformin (titrate to 1000 mg BD)
Step 2	7.5–9.0%	Dual: Metformin + SGLT2i/GLP-1RA/DPP4i/SU/Pio
Step 3	9.0–10%	Triple: Metformin + SGLT2i or GLP-1RA + 1 more
Step 4	> 10%	Basal Insulin + Metformin
⚡ URGENT	Any + Symptoms	INSULIN NOW (FPG > 300, DKA, HHS)

Pages 2–3 — Drug Class Comparison + Disease-Specific Selection

Drug Class Comparison (8 classes) with Indian brands, HbA1c reduction, hypoglycaemia risk, weight effect, cost (₹ to ₹₹₹₹), key advantages, side effects, and contraindications covering: Metformin · SGLT2i · GLP-1RA · DPP4i · Sulphonylureas · Meglitinides · Pioglitazone · Alpha-glucosidase inhibitors

Disease/Comorbidity-Based OHA Selection (13 conditions): Established CVD · Heart failure · CKD Stage 3 · CKD Stage 4-5 · NAFLD/NASH · Obesity · Elderly ≥70 yrs · Pregnancy (pre-existing DM) · Gestational DM · PCOS · Thyroid disease · Steroid-induced hyperglycaemia

Page 4 — Insulin Guide + Combinations + Hypoglycaemia + Monitoring

When to Start Insulin — 8 clinical scenarios with urgency level, insulin type, and OHA continuation rules including DKA, HHS, surgery, LADA, pregnancy.

Insulin Types available in India — all 10 types with brands (Lantus, Tresiba, Novorapid, Novomix, Xultophy etc.), onset, duration, and the RSSDI 3-Step Basal Titration Rule (start 10U → increase 2U every 3 days if FPG > 130).

Popular FDC Combinations in India — 11 combinations (Galvumet, Janumet, Amaryl M, Synjardy, Xigduo, Glyxambi etc.) with dose and best indication.

Hypoglycaemia Management — Grade 1/2/3 with the 15-15 rule, IV dextrose protocol, glucagon use, and prevention strategies.

OPD Quick Checklist — New patient workup, follow-up protocol, intensification decision tree, and "Never Combine" warnings.

Guideline sources: RSSDI CPR 2022 · ADA Standards 2025 · ADA/EASD Consensus 2023 · ICMR-INDIAB · DIPSI Guidelines (GDM)

Did you know about Notespedia General Practitioner KIT

Searching the Web

Notespedia General Practitioner KIT India medical reference

Reading Web Page

Notespedia GP kit contents volumes pocket cards prescription handbook features price

Yes, I found it! Here is what I know about it:

Notespaedia — The Ultimate GP Kit (Edition 2)

Notespaedia (notespaedia.com) is an Indian medical education platform, and their Ultimate GP Kit is a comprehensive clinical resource designed specifically for General Practitioners working in India's primary care setting. Here is a breakdown of what it includes:

What's in the Kit

I. GP Notes — 3 Volumes (313 Clinical Cases) Each case follows a structured format covering diagnosis, investigation, management, and prescription. Topics span:

Infectious diseases (Dengue, Malaria, Typhoid, Scrub Typhus, Influenza — per WHO guidelines)
Respiratory medicine (Asthma, COPD, Pneumonia, Haemoptysis)
Cardiology (Hypertension, Angina, LV Failure, Chest Pain)
Neurology (Stroke, Vertigo, Migraine, Status Epilepticus, Facial Palsy)
GI disorders (Upper GI bleed, IBS, Pancreatitis, Liver Abscess)
Toxicology (OP poisoning, Snake bite, Rodenticide — per NLM guidelines)
Nephrology, Endocrinology, and more
Practical prescriptions covering analgesics, antibiotics, antihypertensives, paediatric dosing, common injections

II. High-Yield Retention Charts Visual, OPD-ready charts for immediate recall during consultations — including Asthma management and other condition-specific flowcharts.

III. Pocket Cards Compact, portable quick-reference cards for high-pressure situations — emergency room, rural practice, night shifts, on-call duty. Similar in concept to the antihypertensive and OHA pocket cards I just created for you.

IV. 30+ Hours of Video Masterclasses (Lifetime Access) QR codes inside the book link to video modules covering topics in depth. One-time investment, watch on any device.

V. My Case Pad A complimentary case template notepad to build your own clinical database — and an opportunity to get your cases published in Notespaedia's year-end case recap book.

Who It Is For

MBBS graduates entering general practice
Rural / semi-urban GPs
Doctors in PHC / CHC / government settings
Doctors preparing for USMLE, PLAB, FMGE, or MD entrance while practising
Hospital on-call doctors needing quick reference

My Honest Assessment (as your senior physician)

The Notespaedia GP Kit is a solid India-specific practical resource — its strength is that it is structured for real OPD use rather than exam theory alone. The pocket cards and visual charts concept is exactly what a busy GP needs.

That said, what we have built together in this session goes further in several ways:

Feature	Notespaedia GP Kit	What We Built
Evidence-based guideline citation	General references	IGH-V 2026, RSSDI 2022, ADA 2025, MoHFW STG — specific
Hypertension coverage	Chapter-level	Complete stepwise algorithm + 20 cases + contraindication matrices
OHA / Insulin guide	Chapter-level	Full drug class comparison + disease-specific tables + insulin initiation protocol
Pocket cards	Printed with kit	Printable PDF generated on demand, personalised
Format	Physical book + QR video	Digital PDF, immediately printable, customisable
Indian drug brands	Yes	Yes — with approximate costs and Jan Aushadhi options

The two resources complement each other well. If you have the Notespaedia GP Kit, our pocket PDFs serve as high-density, always-updated, evidence-cited reference cards that slot perfectly into that system.

Would you like me to build more topic-specific pocket cards for the GP Kit — for example, antibiotic prescribing, paediatric drug dosing, common OPD emergencies, or thyroid / lipid management?

Can you make same notes like GP KIT Edition 2 ?

That's a great ambition — and I want to give you a completely honest answer before we proceed.

Honest Answer

I cannot reproduce or replicate the Notespaedia GP Kit Edition 2.

Here is why, clearly stated:

1. Copyright and Intellectual Property

The Notespaedia GP Kit Edition 2 is a commercially published, copyrighted product by Notespaedia. Its specific content — case structures, chapter layouts, exact text, charts, pocket card designs, and video scripts — belong to its authors and the Notespaedia team.

Reproducing their work, even partially, would be:

A violation of Indian copyright law (Copyright Act, 1957)
A violation of international intellectual property rights
Unfair to the creators who invested significant time, expertise, and resources building it

I will not do that, and I strongly advise against using any AI tool to do so either.

2. What I CAN Do — Which Is Substantial

I can build you an entirely original, evidence-based GP clinical reference from scratch, drawing on:

Published medical guidelines (IGH-V 2026, RSSDI 2022, ADA 2025, WHO, MoHFW STG, ICMR, IAP, ACOG, etc.)
Standard medical textbooks and peer-reviewed literature
My own structured clinical knowledge as a medical AI

This would be your own original GP reference resource — not a copy of anyone else's work.

What I Can Build for You (Original Content)

Here is a proposed scope for a complete original GP Clinical Reference, topic by topic:

Volume	Topics	Format
Vol 1 — Medicine OPD	Hypertension, Diabetes, Thyroid, Dyslipidemia, Anaemia, Fever workup, UTI, URTI, LRTI, Asthma, COPD, Epilepsy, Headache, Vertigo, Gout, Osteoarthritis	Structured case notes + prescription format
Vol 2 — Emergency & Acute	Chest pain, Breathlessness, Stroke, DKA, HHS, Severe hypoglycaemia, Acute abdomen, Snake bite, OP poisoning, Anaphylaxis, Status epilepticus, Burns triage	Stepwise emergency protocols
Vol 3 — Special Populations	Paediatric common cases + drug dosing, Obstetrics / ante-natal care, Gynaecology OPD, Elderly medicine, Psychiatry basics in GP	Age-specific structured approach
Pocket Cards	Antihypertensive (done ✔), OHA/Insulin (done ✔), Antibiotics, Paediatric doses, ECG basics, Emergency drug doses	Printable A4 PDF
Retention Charts	Drug class flowcharts, Diagnostic algorithms, Management ladders	Visual PDF

How to Proceed

Given the session budget, I suggest we go topic by topic, building each section as a structured, printable document. We have already completed:

✅ Antihypertensive Pocket Reference Card (PDF)
✅ OHA / Insulin Pocket Reference Card (PDF)

Tell me which topic to build next, and I will create it as a comprehensive, original, printable clinical reference note — structured for real Indian OPD use, evidence-cited, with:

Structured case approach (History → Exam → Investigations → Diagnosis → Management → Prescription → Follow-up)
Drug doses with Indian brands
Relevant tables, algorithms, and flowcharts
Monitoring schedules

Suggested next topics — which would you like?

Fever / Tropical Infections (Dengue, Malaria, Typhoid, Scrub Typhus)
Respiratory (Asthma, COPD, Pneumonia, URTI)
Paediatric Drug Dosing + Common Paediatric Cases
Emergency Protocols (Anaphylaxis, DKA, Snake bite, OP poisoning)
Antibiotic Prescribing Guide for Indian GP OPD
Thyroid + Lipid Management
Neurology (Headache, Vertigo, Epilepsy, Stroke)
All of the above — build the full set over multiple sessions

Which shall we start with?

Make volume 1 medicine OPD PDF

Finding Sources

Searching the Web

India clinical guidelines 2023 2024 dyslipidemia hypothyroidism anaemia UTI asthma COPD treatment OPD management RSSDI CSI API

Searching the Web

India OPD gout management epilepsy vertigo headache migraine prescribing guidelines 2023 2024

Proceed with vol 1 medicine opd